Wiley Blackwell

SHERPA: Unknown

People

  1. Brogi
    Brogi
  2. Wen
    Wen
  3. Pareja Zea
    Pareja Zea
  4. Weigelt
    Weigelt
  5. Murray
    Murray
  6. Edelweiss
    Edelweiss
  7. Morrow
    Morrow
  8. Kuba
    Kuba
  9. Ross
    Ross
  10. Da Silva
    Da Silva

Groups

  1. Department of Pathology and Laboratory Medicine (41)
  2. GSK Faculty (17)
  3. Department of Medicine (12)
  4. Solid Tumor Oncology Division (12)
  5. Surgery (12)
  6. Breast Medicine Service (11)
  7. GDMT, Pathology and Laboratory Medicine (11)
  8. Gynecology Disease Management Team (11)
  9. Sloan Kettering Institute Postdocs (8)
  10. Survivorship Research (6)
Search Within
  1. "Edi Brogi"
Formats
  1. Journal Article (34)
  2. Review (4)
  3. Meeting Abstract (2)
  4. Editorial (1)
Groups
  1. Department of Pathology and Laboratory Medicine (41)
  2. GSK Faculty (17)
  3. Department of Medicine (12)
  4. Solid Tumor Oncology Division (12)
  5. Surgery (12)
  6. Breast Medicine Service (11)

More Groups

People
  1. Edi Brogi (41)
  2. Hannah Wen (14)
  3. Jorge Reis-Filho (11)
  4. Britta Weigelt (10)
  5. Fresia Pareja Zea (10)
  6. Melissa Murray (9)

More People

Years
  1. 2025 (4)
  2. 2024 (1)
  3. 2023 (1)
  4. 2021 (3)
  5. 2020 (5)
  6. 2019 (3)

More Years

Publications
  1. Histopathology (21)
  2. Breast Journal (8)
  3. Cancer (8)
  4. Journal of Pathology (3)
  5. Journal of Pathology: Clinical Research (1)

Results (41)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinicopathological features of microinvasive lobular carcinoma
    Journal Article

    Han, R.; Hashmi, A. A.; Wen, H. Y.; Murray, M.; Kuba, M. G.; Seidman, A. D.; Morrow, M.; Brogi, E.
    Histopathology (2025)

    Fulltext@MSK | Save
  • Malignant phyllodes tumours of the breast: The case for revising WHO’s ‘full house’ diagnostic criteria
    Review

    Tan, P. H.; Ellis, I. O.; Allison, K. H.; Badve, S. S.; Brogi, E.; Callagy, G.; Charafe-Jauffret, E.; Chen, C. J.; Chen, Y. Y.; Collins, L. C.; more...
    Histopathology (2025)

    Fulltext@MSK | Save
  • Variability in the diagnosis and reporting of metaplastic breast carcinoma: Results of an international survey
    Journal Article

    Yang, E.; Fineberg, S.; Mohamed, A.; Brogi, E.; Wen, H.
    Histopathology (2025)

    Fulltext@MSK | Save
  • Discordance of human epidermal growth factor receptor 2-low status between breast primary and distant metastases with clinical–pathological correlation
    Journal Article

    Yang, E.; D'Alfonso, T. M.; Morrow, M.; Brogi, E.; Wen, H. Y.
    Histopathology (2025)

    Fulltext@MSK | Save
  • Radial sclerosing lesions found on core needle biopsy: Excision can be safely avoided
    Journal Article

    Grabenstetter, A.; Brennan, S. B.; Jochelson, M. S.; Brogi, E.; Morrow, M.; Tan, L. K.; D'Alfonso, T. M.
    Histopathology (2024)

    Fulltext@MSK | Save
  • Update on lobular lesions of the breast
    Review

    Kuba, M. G.; Brogi, E.
    Histopathology (2023)

    Fulltext@MSK | Save
  • The impact of MYC gene amplification on the clinicopathological features and prognosis of radiation-associated angiosarcomas of the breast
    Journal Article

    Kuba, M. G.; Xu, B.; D’Angelo, S. P.; Rosenbaum, E.; Plitas, G.; Ross, D. S.; Brogi, E.; Antonescu, C. R.
    Histopathology (2021)

    Fulltext@MSK | Save
  • Whole-exome sequencing analysis of juvenile papillomatosis and coexisting breast carcinoma
    Journal Article

    D'Alfonso, T. M.; Pareja, F.; Da Cruz Paula, A.; Vahdatinia, M.; Gazzo, A.; Ferrando, L.; da Silva, E. M.; Cheng, E.; Sclafani, L.; Chandarlapaty, S.; more...
    Journal of Pathology: Clinical Research (2021)

    Fulltext@MSK | Save
  • Next-generation assessment of human epidermal growth factor receptor 2 gene (ERBB2) amplification status in invasive breast carcinoma: A focus on Group 4 by use of the 2018 American Society of Clinical Oncology/College of American Pathologists HER2 testing guideline
    Journal Article

    Hoda, R. S.; Bowman, A. S.; Zehir, A.; Razavi, P.; Brogi, E.; Ladanyi, M.; Arcila, M. E.; Wen, H. Y.; Ross, D. S.
    Histopathology (2021)

    Fulltext@MSK | Save
  • The path to a better biomarker: Application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice
    Review

    Gonzalez-Ericsson, P. I.; Stovgaard, E. S.; Sua, L. F.; Reisenbichler, E.; Kos, Z.; Carter, J. M.; Michiels, S.; Le Quesne, J.; Nielsen, T. O.; Lænkholm, A. V.; more...
    Journal of Pathology (2020)

    Fulltext@MSK | Save